Thyrotoxicosis / the clinical syndrome of hypermeta-olism that res:lts when the ser:m concentrations of free T 4, T 3, or -oth are increased. Hyperthyroidism / S:stained increases in thyroid hormone -iosynthesis and secretion -y the thyroid gland.
Thyrotoxicosis / the clinical syndrome of hypermeta-olism that res:lts when the ser:m concentrations of free T 4, T 3, or -oth are increased. Hyperthyroidism / S:stained increases in thyroid hormone -iosynthesis and secretion -y the thyroid gland.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Thyrotoxicosis / the clinical syndrome of hypermeta-olism that res:lts when the ser:m concentrations of free T 4, T 3, or -oth are increased. Hyperthyroidism / S:stained increases in thyroid hormone -iosynthesis and secretion -y the thyroid gland.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
Penyakit DaIam FK USU / RSUP HAM Medan HYPERTHYRO!D!SN HYPERTHYRO!D!SN Anatomy of the Thyroid Gland %iroid Disease Aspect fungtion morphology eutiroid, hypertiroid, hypotiroid normal, atrophic, nodule, diffus :lti Nod:le
Hyperthyroidism Low High High S:-clinical Hypothyroidsm High normal normal S:-clinical Hyperthyroidsm Low normal normal Thyrotoxicosis and Hyperthyroidism Definitions Thyrotoxicosis The clinical syndrome of hypermeta-olism that res:lts when the ser:m concentrations of free T 4 , T 3 , or -oth are increased Hyperthyroidism S:stained increases in thyroid hormone -iosynthesis and secretion -y the thyroid gland The 2 terms are not synonymo:s Braverman LE, et al. Werner & Ingbar's %e %roid. A Fundamental and Clinical %ext. 8th ed. 2000. %yroid Storm Rare complication of hyperthyroidism where manifestations of thyrotoxicosis -ecome life threatening. Also may -e termed %yrotoxic Crisis. Apatetic %yrotoxicosis Rare form :s:ally occ:rring in the elderly. Often presents as single organ fail:re (CHF). Patient may develop thyroid storm witho:t the typical manifestations. Prevalence of Thyrotoxicosis n a cross-sectional st:dy of :r-an and r:ral ad:lts, the prevalence of thyrotoxicosis ranged from 1.9% to 2.7% in women 0.16% to 0.23% in men T:n-ridge WG, et al. Clin Endocrinol. 1977;7:481-493. Hypertyroidism EtioIogy Graves' disease MuItinoduIar goiter Autonomous noduIe Exogenous tyroid ormone %ransient-subacute tyroiditis, postpartum tyroiditis Drugs-amiodarone Causes of %yrotoxicosis Divided by Degree of Radioiodine Uptake Hig I 123 Uptake Graves' disease Toxic nod:lar goiter TSH-mediated thyrotoxicosis Pit:itary t:mor Pit:itary resistance to thyroid hormone HCG-mediated thyrotoxicosis Hydatidiform mole Choriocarcinoma Other HCG-secreting t:mors Thyroid carcinoma (very rare)
of Thyrotoxicosis Symptoms Signs Nervo:sness Hyperactivity Fatig:e Tachycardia Weakness Systolic hypertension ncreased perspiration Warm, moist, or smooth skin Heat intolerance Stare and eyelid retraction Tremor Tremor Hyperactivity Hyperreflexia Palpitations :scle weakness Appetite/weight changes enstr:al dist:r-ances Braverman LE, et al. Werner & Ingbar's %e %roid. A Fundamental and Clinical %ext. 8th ed. 2000. SYSTEC EFFECTS RESPRATORY Dyspnea, panting, hyperventalation respiratory m:scle weakness increased tiss:e car-on dioxide levels +/- congestive heart fail:re SYSTEC EFFECTS CARDOVASCULAR Thyrotoxic cardiomyopathy Hypermeta-olic state Systemic hypertension Direct T3 and T4 action on heart m:scle LV hypertrophy, VS hypertrophy, RA and aortic dilation, enhanced contractility 1. Graves' Disease (Toxic Diff:se Goiter) The most common ca:se of hyperthyroidism Acco:nts for 60% to 90% of cases ncidence in the United States estimated at 0.02% to 0.4% of the pop:lation Affects more females than males, especially in the reprod:ctive age range Graves disease is an a:toimm:ne disorder possi-ly related to a defect in imm:ne tolerance Graves Disease A:toimm:ne disorder Prod:ction of TSH receptor a:toanti-odies Stim:late thyroid hormone overprod:ction Characterized -y the presence of B- and T- lymphocytes in thyroid tiss:e TSH receptor activation Thyroglo-:lin and thyroid peroxidase anti-odies Sodi:m/iodide cotransporter (NS) activity enhanced (increased RA) A:toantigens A--ott La-oratories Diagnostics Division We- site. Availa-le at: et al. Werner & Ingbar's %e %roid. A Fundamental and Clinical %ext. 8th ed. 2000. Graves' Disease Goiter Hyperthyroidism Exophthalmos Localized myxedema Thyroid acropachy Thyroid stimulating immunoglobulins linical haracteristics of Goiter in Graves` Disease Diffuse increase in thyroid gland size Soft to slightly firm Non-nodular Bruit and/or thrill Mobile Non-tender Without prominent adenopathy Graves` Disease - Localized Myxedema Margins sharply demarcated Thickened skin Nodularity Margins sharply demarcated Graves' Ophthalmopathy Class one: spasm of :pper lids with thyrotoxicosis Class two: perior-ital edema and chemosis Class three: proptosis Class fo:r: extraoc:lar m:scle involvement Class five: corneal involvement Class six: loss of vision d:e to optic nerve involvement DAGNOSTCS Endocrine Testing Total T4: 5-10% will -e normal Total T3: 30% will -e normal Free T4: false negative with NT and shipping fT4 -etter T3 s:pression TRH stim:lation and TSH response DAGNOSTCS RADONUCLDE AGNG Pertechnetate imaging extent of involvement detect metastasis to other gland no palpa-le enlargement (within thorax) Carcinoma metastasis 2. Toxic :ltinod:lar Goiter ore common in places with lower iodine intake Acco:nts for less than 5% of thyrotoxicosis cases in iodine-s:fficient areas Evol:tion from sporadic diff:se goiter to toxic m:ltinod:lar goiter is grad:al Thyrotropin receptor m:tations and TSH m:tations have -een fo:nd in some patients with toxic m:ltinod:lar goiters Th/ S:rgery or 131 is recommended treatment Braverman LE, et al. Werner & Ingbar's %e %roid. A Fundamental and Clinical %ext. 8th ed. 2000. Toxic :ltinod:lar Goiter NG is an enlarged thyroid gland containing m:ltiple nod:les The thyroid gland -ecomes more nod:lar with increasing age n NG, nod:les typically vary in size ost NGs are asymptomatic NG may -e toxic or nontoxic Toxic NG occ:rs when m:ltiple sites of a:tonomo:s nod:le hyperf:nction develop, res:lting in thyrotoxicosis Toxic NG is more common in the elderly 3. Toxic Adenoma A:tonomo:sly f:nctioning thyroid nod:le hypersecreting T3 and T4 res:lting in thyrotoxicosis (Pl:mmer's disease) Almost never malignant anage with antithyroid dr:gs followed -y either -131 or s:rgery La-oratory Testing in Thyroid Disease TSH: Pit:itary hormone which stim:lates thyroid ay rise transiently in recovery from other illness Free T4: direct meas:re of thyroxine activity ay -e transiently s:ppressed in severe ac:te illness Free T3: s:spect hyperthyroid -:t normal FT4 Thyroid peroxidase/thyroperoxidase anti-ody: Anti-TPO High levels in Hashimoto's (95%) & Graves TSH receptor stim:lating A- meas:res activity in Graves-:se in pregnancy Scans/Ultraso:nd Radioiodine :ptake (RAU) Thyroid Scan Ultraso:nd Fine needle Aspiration Treatment of Hyperthyroidism 1. Antithyroid dr:gs 2. S:rgical resection 3. Radioactive iodine therapy Braverman LE, et al. Werner & Ingbar's %e %roid. A Fundamental and Clinical %ext. 8th ed. 2000. 1. Antithyroid Dr:g Therapy Ac:te hyperthyroid symptoms Goal of therapy: nhi-it peripheral conversion of T4 to T3 nhi-it synthesis and release of T4 and T3 from thyroid gland Propylthio:racil (PTU) ethimazole [generic] or Tapazole Antithyroid Dr:g Therapy A. PTU: nhi-its peripheral conversion of T4 to T3 nhi-its thyroid hormone synthesis and release from thyroid gland B. ethimazole [generic]: nhi-its thyroid hormone synthesis and release from thyroid gland C. Beta--locker therapy: Ameliorates tachycardia, sweating, tremor, nervo:sness Propanolol: starting dose 20-40 mg PO q6h Ca:tion in patients with CHF or -ronchospasm 2. S:-total Thyroidectomy S:rgical complications: Vocal cord paralysis (1%) Hypothyroidism (:p to 43% after 10 years) Hypoparathyroidism Rec:rrence of hyperthyroidism (10-15%) 3. Radioactive odine 131 [] A-lation Treatment of choice in patients > 21 years old with Graves' Disease Treatment of choice in patients < 21 years old witho:t remission after antithyroid dr:g therapy Treatment of choice in patients with toxic m:ltinod:lar goiter or toxic thyroid adenoma Radioactive odine A-lation (cont') Single dose of 131 [] orally 80% e:thyroid after single dose > 50% of patients will develop hypothyroidism Assay TSH every 3 months after therapy Radioactive odine A-lation (Cont') Levothyroxine therapy when patient -ecomes hypothyroid Life-long Levothyroxine therapy RA contraindicated in pregnancy, lactation, iodine allergy Screen pre-menopa:sal women for pregnancy prior to treatment Thyroid Storm A life-threatening crisis . Estimated mortality : 20-30% . the res:lt of thyroid s:rgery . Ca:sed more often -y antecedent Grave's disease . Precipitants of Thyroid Storm S:rgery . Radioiodine therapy . odinated contrast dyes . Thyroid hormone ingestion . Dia-etic Ketoacidosis . Cere-rovasc:lar accident . P:lmonary em-olism and CHF . Pathophysiology of Thyroid Storm 1) An ac:te decrease in thyroxine- -inding glo-:lin => high levels of free hormone . 2) Thyroid hormone increases the density of -eta-adrenergic receptors & alters responsiveness to catecholamines at a postreceptor level . La-oratory Diagnosis of Thyroid Storm A com-ination of low TSH and elevated free T4 => makes the diagnosis . f TSH is lower than normal and free T4 is normal => free T3 testing is recommended . ED meas:rement of thyroglo-:lin or thyroid anti-odies : No indication . Treatment of Thyroid Storm Block hormone synthesis with either : a) Propylthio:racil 100-600 mg loading PO or NG , 200-250 mg q4h for total daily dose of 1200-1500 mg ; or -) methimazole 20 mg PO ( 10-40 mg range ) q 4h . Treatment of Thyroid Storm ( contin:ed ) nhi-it hormone release : odides Potassi:m iodide ( SSK ) 5 drops PO Q6-8H , or L:gol's sol:tion 7-8 drops ( 1 mL PO Q6H ) or podate 1-3 g daily ( as 1 g Q8H for 24 ho:rs , then 500 mg Q12H ) . f severe iodide allergy , lithi:m car-onate 300 mg Q6H . Treatment of Thyroid Storm ( contin:ed ) Gl:cocorticoids : Hydrocortisone ( 300 mg V , then 100 mg V q8h ) ; dexamethasone ( 2 mg Q6H ) . Adrenergic -lockade : Propranolol ( 0.5- 3 mg V over 15 min:tes slow V , then 60-80 mg PO Q4H ) ; Esmolol ( 0.25-0.5 mcg/kg loading , inf:sion of 0.05-0.1 mcg/kg/min ) . Adj:nctive Therapy for Thyroid Storm Treat fever aggressively with acetaminophen . V fl:id containing 10% dextrose are recommended . Administer vitamin s:pplements , incl:ding thiamine . Treat CHF with conventional methods . Adj:nctive Therapy for Thyroid Storm ( contin:ed ) dentify the precipitating event , incl:ding infection . Consider plasmapheresis , hemodialysis or peritoneal dialysis for removal of meta-olically active hormone . Thyrotoxic Periodic Paralysis ost common ca:se of hypokalemic periodic paralysis Flaccid paralysis Lower extremities affected most often Oc:lar and -:l-ar m:scles :ninvolved, respiratory m:scles rarely involved ost often starts d:ring sleep Precipitated following exercise, high salt intake or high car-ohydrate diet Hypokalemia d:ring the paralysis THANK YOU!!!!!